GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Diasorin SpA (OTCPK:DSRLF) » Definitions » ROE % Adjusted to Book Value

Diasorin SpA (Diasorin SpA) ROE % Adjusted to Book Value : 3.95% (As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Diasorin SpA ROE % Adjusted to Book Value?

Diasorin SpA's ROE % for the quarter that ended in Dec. 2023 was 12.51%. Diasorin SpA's PB Ratio for the quarter that ended in Dec. 2023 was 3.17. Diasorin SpA's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was 3.95%.

Diasorin SpA ROE % Adjusted to Book Value Historical Data

The historical data trend for Diasorin SpA's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diasorin SpA ROE % Adjusted to Book Value Chart

Diasorin SpA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.93 2.95 3.61 3.31 3.35

Diasorin SpA Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.04 3.02 3.62 2.22 3.95

Competitive Comparison of Diasorin SpA's ROE % Adjusted to Book Value

For the Diagnostics & Research subindustry, Diasorin SpA's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Diasorin SpA's ROE % Adjusted to Book Value Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Diasorin SpA's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Diasorin SpA's ROE % Adjusted to Book Value falls into.


Diasorin SpA ROE % Adjusted to Book Value Calculation

Diasorin SpA's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=10.61% / 3.17
=3.35%

Diasorin SpA's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=12.51% / 3.17
=3.95%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Diasorin SpA ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Diasorin SpA's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Diasorin SpA (Diasorin SpA) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Diasorin SpA (OTCPK:DSRLF) » Definitions » ROE % Adjusted to Book Value
Comparable Companies
HKSE:08070 HKSE:01379 HKSE:01273 HKSE:01591 HKSE:00380 HKSE:01629 HKSE:00544 HKSE:01758 HKSE:00379 HKSE:01720 TSE:2309 TMO DHR IQV IDXX XSWX:LONN A MTD ICLR ILMN
Traded in Other Exchanges
DIA:Italy 0GZX:UK 34D:Germany
Address
Via Crescentino Snc, Saluggia, Vercelli, ITA, 13040
Website
https://www.diasoringroup.com
Diasorin SpA is a biotechnology company engaged in developing, producing, and marketing reagent kits for laboratory diagnostics around the world. The business has focused on the immunodiagnostic market, molecular diagnostics, and Life Science sector. The company has a presence in Italy, Europe, North America, and the Rest of the world, where the majority of its revenue is from North America followed by Italy.